Kyorin Pharmaceutical Co Ltd 2025 Integrated Report
Company: Kyorin Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Integrated Report
Pages: 57
The report presents fiscal 2024 as a record year, with consolidated net sales of ¥130,087 million and operating profit of ¥12,567 million. It highlights climate progress, with Scope 1 + Scope 2 emissions of 24,275 t and a 27.7% reduction from fiscal 2015. The company also describes a 2050 carbon-neutrality commitment and a 2030 reduction target of 46%. Human-capital priorities include increasing women's representation in management to 15% by 2030.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.